Clinical trial

Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide…

NCT00135551 · Seiji Umemoto, M.D., Ph.D., Other · Completed

Key facts

NCT number NCT00135551
Title Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients
Official title The Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial
Acronym COPE
Lead sponsor Seiji Umemoto, M.D., Ph.D., Other
Collaborators The Japanese Society of Hypertension Yamaguchi University Hospital Kyowa Hakko Kogyo Co., Ltd. Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Cardiovascular Disease
Intervention type Drug
Interventions Angiotensin receptor blockers, β-blockers, thiazide diuretics
Enrollment 3,501
Start date May 1, 2003
Primary completion May 1, 2010
Completion Nov 1, 2010
First posted Aug 26, 2005
Last update posted Feb 22, 2012
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies